drugset / Trial / NCT00301392

Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT)

NCT00301392

Phase 4 Completed 1240 enrolled Tokyo University
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the effects of pitavastatin for preventing diabetes in a population with impaired glucose tolerance.

Timeline

Start
2006-04
Primary completion
2012-03
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pitavastatin Small molecule 1 mg
Subject Pitavastatin Small molecule 2 mg